Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Exosomes and microRNAs: Molecular Mediators Linking Obesity, Exercise, and Metabolic Regulation.

Joaquim VHA., Pereira NP., Improta-Caria AC., de Avila Pelozin BR., Fernandes T., Oliveira EM.

Narrative Review on Type 2 Diabetes, Chronic Inflammation, published in Curr Diab Rep (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Curr Diab Rep (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41105175
DOI
10.1007/s11892-025-01608-z

Abstract (original English)

PURPOSE OF REVIEW: Obesity is a global health crisis characterized by chronic inflammation and metabolic dysfunction, partly driven by altered intercellular communication within the adipose tissue. Exosomes, small extracellular vesicles, and their microRNA (miRNA) cargo have emerged as key mediators in this process, facilitating crosstalk between adipose tissue and other organs and influencing insulin sensitivity, inflammation, and energy homeostasis. Physical exercise modulates the expression and secretion of exosomal miRNAs, contributing to systemic metabolic improvements and counteracting obesity-related diseases. This study reviews recent research on the causal role of exosomes in obesity-related metabolic dysfunction. RECENT FINDINGS: Exosome-derived miRNAs are often deregulated in obese individuals, promoting adipose tissue hypertrophy, systemic insulin resistance, and chronic inflammation. Specific miRNAs (e.g., miR-34a, miR-29a, miR-222, miR-155, and miR-27a) have been implicated in impairing insulin signaling and promoting pro-inflammatory states. Exercise-induced exomiRs (e.g., miR-1, miR-133b, and miR-22) mediate beneficial effects, such as enhanced lipolysis, improved insulin sensitivity, and reduced inflammation. Experimental models have shown that exosomes from trained animals can transfer these benefits to their sedentary or obese counterparts. Exosomes and their

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
MicroRNAsExosomesHumansObesityExerciseAnimalsAdipose TissueInsulin ResistanceInflammationEnergy Metabolism

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research